These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28206698)

  • 21. CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII.
    Fratzl-Zelman N; Morello R; Lee B; Rauch F; Glorieux FH; Misof BM; Klaushofer K; Roschger P
    Bone; 2010 Mar; 46(3):820-6. PubMed ID: 19895918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
    Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
    Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FKBP65-dependent peptidyl-prolyl isomerase activity potentiates the lysyl hydroxylase 2-driven collagen cross-link switch.
    Chen Y; Terajima M; Banerjee P; Guo H; Liu X; Yu J; Yamauchi M; Kurie JM
    Sci Rep; 2017 Apr; 7():46021. PubMed ID: 28378777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel transgenic murine model with persistently brittle bones simulating osteogenesis imperfecta type I.
    Liu Y; Wang J; Liu S; Kuang M; Jing Y; Zhao Y; Wang Z; Li G
    Bone; 2019 Oct; 127():646-655. PubMed ID: 31369917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization.
    Fratzl-Zelman N; Barnes AM; Weis M; Carter E; Hefferan TE; Perino G; Chang W; Smith PA; Roschger P; Klaushofer K; Glorieux FH; Eyre DR; Raggio C; Rauch F; Marini JC
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3516-25. PubMed ID: 27383115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights on the clinical variability of FKBP10 mutations.
    Essawi OH; Tapaneeyaphan P; Symoens S; Gistelinck C C; Malfait F; Eyre DR; Essawi T; Callewaert B; Coucke PJ
    Eur J Med Genet; 2020 Sep; 63(9):103980. PubMed ID: 32531462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta.
    Sinder BP; Eddy MM; Ominsky MS; Caird MS; Marini JC; Kozloff KM
    J Bone Miner Res; 2013 Jan; 28(1):73-80. PubMed ID: 22836659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygosity for CREB3L1 premature stop codon in first case of recessive osteogenesis imperfecta associated with OASIS-deficiency to survive infancy.
    Lindahl K; Åström E; Dragomir A; Symoens S; Coucke P; Larsson S; Paschalis E; Roschger P; Gamsjaeger S; Klaushofer K; Fratzl-Zelman N; Kindmark A
    Bone; 2018 Sep; 114():268-277. PubMed ID: 29936144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severely Impaired Bone Material Quality in Chihuahua Zebrafish Resembles Classical Dominant Human Osteogenesis Imperfecta.
    Fiedler IAK; Schmidt FN; Wölfel EM; Plumeyer C; Milovanovic P; Gioia R; Tonelli F; Bale HA; Jähn K; Besio R; Forlino A; Busse B
    J Bone Miner Res; 2018 Aug; 33(8):1489-1499. PubMed ID: 29665086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.
    Staab-Weijnitz CA; Fernandez IE; Knüppel L; Maul J; Heinzelmann K; Juan-Guardela BM; Hennen E; Preissler G; Winter H; Neurohr C; Hatz R; Lindner M; Behr J; Kaminski N; Eickelberg O
    Am J Respir Crit Care Med; 2015 Aug; 192(4):455-67. PubMed ID: 26039104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel mutations of the SERPINF1 and FKBP10 genes in Chinese families with autosomal recessive osteogenesis imperfecta.
    Zhang H; Xu Y; Yue H; Wang C; Gu J; He J; Fu W; Hu W; Zhang Z
    Int J Mol Med; 2018 Jun; 41(6):3662-3670. PubMed ID: 29512769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoblast-Specific Loss of IGF1R Signaling Results in Impaired Endochondral Bone Formation During Fracture Healing.
    Wang T; Wang Y; Menendez A; Fong C; Babey M; Tahimic CG; Cheng Z; Li A; Chang W; Bikle DD
    J Bone Miner Res; 2015 Sep; 30(9):1572-84. PubMed ID: 25801198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment.
    Fiscaletti M; Biggin A; Bennetts B; Wong K; Briody J; Pacey V; Birman C; Munns CF
    Bone; 2018 May; 110():66-75. PubMed ID: 29382611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.
    Lindahl K; Barnes AM; Fratzl-Zelman N; Whyte MP; Hefferan TE; Makareeva E; Brusel M; Yaszemski MJ; Rubin CJ; Kindmark A; Roschger P; Klaushofer K; McAlister WH; Mumm S; Leikin S; Kessler E; Boskey AL; Ljunggren O; Marini JC
    Hum Mutat; 2011 Jun; 32(6):598-609. PubMed ID: 21344539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mutations in FKBP10 in Chinese patients with osteogenesis imperfecta and their treatment with zoledronic acid.
    Xu XJ; Lv F; Liu Y; Wang JY; Ma DD; Asan ; Wang JW; Song LJ; Jiang Y; Wang O; Xia WB; Xing XP; Li M
    J Hum Genet; 2017 Feb; 62(2):205-211. PubMed ID: 27762305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of conditional inactivation of beta 1 integrins using twist 2 Cre, Osterix Cre and osteocalcin Cre lines on skeletal phenotype.
    Shekaran A; Shoemaker JT; Kavanaugh TE; Lin AS; LaPlaca MC; Fan Y; Guldberg RE; García AJ
    Bone; 2014 Nov; 68():131-41. PubMed ID: 25183373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel homozygous 5 bp deletion in FKBP10 causes clinically Bruck syndrome in an Indonesian patient.
    Setijowati ED; van Dijk FS; Cobben JM; van Rijn RR; Sistermans EA; Faradz SM; Kawiyana S; Pals G
    Eur J Med Genet; 2012 Jan; 55(1):17-21. PubMed ID: 22085994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations.
    Joeng KS; Lee YC; Jiang MM; Bertin TK; Chen Y; Abraham AM; Ding H; Bi X; Ambrose CG; Lee BH
    Hum Mol Genet; 2014 Aug; 23(15):4035-42. PubMed ID: 24634143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations That Alter the Carboxy-Terminal-Propeptide Cleavage Site of the Chains of Type I Procollagen Are Associated With a Unique Osteogenesis Imperfecta Phenotype.
    Cundy T; Dray M; Delahunt J; Hald JD; Langdahl B; Li C; Szybowska M; Mohammed S; Duncan EL; McInerney-Leo AM; Wheeler PG; Roschger P; Klaushofer K; Rai J; Weis M; Eyre D; Schwarze U; Byers PH
    J Bone Miner Res; 2018 Jul; 33(7):1260-1271. PubMed ID: 29669177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HSP47 and FKBP65 cooperate in the synthesis of type I procollagen.
    Duran I; Nevarez L; Sarukhanov A; Wu S; Lee K; Krejci P; Weis M; Eyre D; Krakow D; Cohn DH
    Hum Mol Genet; 2015 Apr; 24(7):1918-28. PubMed ID: 25510505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.